Name |
Title |
Since |
Bio |
Dr Yanheng Wu |
Non-Executive Director |
Dec 2018 |
Dr Yanheng Wu
Non-Executive Director
Dr Wu is the President and Vice chair of Constellation International (Group) Holdings Ltd. In 2016, he established Guangzhou Hearty-Care Biotechnology Ltd., a medical technology company that is now owned by Constellation International (Group) Holdings Ltd. He holds multiple biomedical patents.
|
Mr Stephen (Steve) Denaro |
Company Secretary, Non-Executive Director |
Oct 2018 |
Mr Stephen (Steve) Denaro
Company Secretary, Non-Executive Director
Mr Denaro has more than 30 years of senior level and Board level experience across publicly listed companies; serving as Chief Financial Officer, Company Secretary and Director. He has experience in managing compliance with finance and accounting regulatory requirements. He has managed investment acquisitions and subsequent funding (domestic and international). He also chairs the Risk Management Committee.
|
Dr Wenyi Gu |
Non-Executive Director |
Oct 2018 |
Dr Wenyi Gu
Non-Executive Director
Dr Gu works as Research Fellow for the Australian Institute for Bioengineering and Nanotechnology at The University of Queensland (UQ), where he began his post-doctoral work in 2001. He was supported by the National Health and Medical Research Council (NHMRC) to work at Harvard Medical School, Harvard University as a visiting research fellow. Before he was into nano medicine (focusing on drug delivery and cancer therapy), he worked on RNAi-based gene therapy for several years at Translation Research Institute (TRI). His research has been published in respected industry journals such as Nature Communications, Ad. Materials, ACS Nano and PNAS USA. He is a Nominee Non-Executive Director for major shareholder, Star Bright Holding Ltd. He is also a member of Risk Management Committee.
|
Mr Mathew James Ratty |
Executive Director, Chief Executive Officer, Managing Director |
Dec 2017 |
Mr Mathew James Ratty
Executive Director, Chief Executive Officer, Managing Director
Mr Ratty is an experienced investor in Australian and US equity and debt markets. He has experience across capital raising advice, seed investment negotiation, corporate strategy and financial modelling. He is the co-founder of MC Management Group Pty Ltd. At MC Management Group Pty Ltd Mr Ratty holds the position of Head of Investment and is responsible for negotiating deal structures and asset pricing for companies in the healthcare, financial and technology space. Prior to this, Mr Ratty was a director and analyst at property development and equity company, Gladstone Bridge.
|
Mr Robert (Rob) E.T Towner |
Non-Executive Director |
Feb 2017 |
Mr Robert (Rob) E.T Towner
Non-Executive Director
Mr Towner has over 20 years of experience in the corporate advisory and finance sectors. He was appointed Managing Director & CEO of Triangle Energy (Global) Ltd in July 2014 and managed the Company's transition from operating Indonesian based assets to establishing a portfolio of Australian oil and gas projects, including the producing Cliff Head Oil Field and associated infrastructure in the Perth Basin, Western Australia. Rob has experience in the oil and gas sector and has been involved in a number of capital raisings for projects throughout Australia, Canada, Asia and the USA since the early 1990's. Rob represents Triangle's 32.68% interest on the board of State Gas Ltd as a non-executive Director.
|
Mr Wayne Paterson |
Managing Director, Chief Executive Officer |
Feb 2016 |
Mr Wayne Paterson
Managing Director, Chief Executive Officer
Mr Paterson has held senior positions in multi national pharmaceutical companies during the past 25 years. Throughout his career, he has been responsible for building and managing multi-billion dollar businesses throughout the world, including mergers, integrations, acquisitions and major restructures as President and CEO. From 2005 to 2013 he held senior positions at Merck Kgaa, most recently as President of Europe, Canada and Australia. Prior to this, he was President of Emerging Markets, President of Japan and Global Head of Cardiovascular Medicine. Between 1999 and 2005, he served at Roche Pharmaceuticals where he was most recently Head of Pharmaceuticals in Roche's South Korean operation. He also served as Head of Commercial Operations for Roche China based in Shanghai. He held as a director in Cepheid Inc from April 2015 to November 2016.
|
Mr John Seaberg |
Non-Executive Director, Non-Executive Chairman |
Oct 2014 |
Mr John Seaberg
Non-Executive Director, Non-Executive Chairman
Mr Seaberg served as Chairman of the Board of Synovis Inc, a Minneapolis based manufacturer of various medical devices and bio scaffold tissue products from 2008 until its sale to Baxter in 2012. From 2007 until 2014 he was Founder, Chairman and CEO of NeoChord Inc., a venture capital backed company commercializing technology developed at the Mayo Clinic for the repair of the mitral valve via minimally invasive techniques. From 1996 to 2006, he served at Guidant Corp (subsequently acquired by Boston Scientific Corp) where he served in various executive level positions including Director of Bradycardia Marketing for Cardiac Rhythm Management, Vice President of Sales for Cardiac Surgery and Vice President of Sales for Cardiac Rhythm Management. In 1991, he was co-founder of ACIST Medical and served as its first President and CEO. He is also a member of Member of the Risk Management Committee.
|
Mr Robert Norman Scott |
Lead, Non-Executive Director |
Mar 2013 |
Mr Robert Norman Scott
Lead, Non-Executive Director
Mr Scott has over 35 years' experience as a corporate advisor. Mr. Scott is a former senior partner of the international accounting firms of KPMG and Arthur Andersen. Mr. Scott is the Chair of the Risk and Disclosure Committee.
|
Mr Peter R Turvey |
Non-Executive Director, Non-Executive Deputy Chairman |
Mar 2012 |
Mr Peter R Turvey
Non-Executive Director, Non-Executive Deputy Chairman
Mr Turvey has had more than 30 years of experience in the biotech/pharmaceutical industry having been former Executive Vice President Licensing, Group General Counsel and Company Secretary of global biopharmaceutical company CSL, retiring in 2011. He was also part of the protection and licensing of CSL's intellectual property and for risk management within CSL, which included management of the internal audit function, reporting to the Audit & Risk Management Committee of the Board as well as being the Chairman of the Corporate Risk Management Committee. In his senior executive role at CSL, he was part of CSL's M&A and equity capital raising activities over a 15 year period, including during the time of the float of CSL as a publicly listed company. In addition to his expertise in corporate finance, audit and risk management, Mr Turvey has experience in commercialisation and pharmaceutical product development. Mr Turvey is currently Chairman of ImmVirX Pty Ltd, a NonExecutive Director of Cell Therapies Pty Ltd (a subsidiary of the Peter MacCallum Cancer Centre), and a director of Agriculture Victoria Services Pty Ltd and Phytogene Pty Ltd. He is Chairman of the Risk Committee.
|
Ms Catherine (Kate) Mary Costello |
Non-Executive Director, Non-Executive Chairman |
Aug 2005 |
Ms Catherine (Kate) Mary Costello
Non-Executive Director, Non-Executive Chairman
Ms Costello is a professional, Non-executive Director having sold her consultancy, Governance Matters, in 2017. Prior to establishing Governance Matters she worked in management at a commercial law firm and is an expert in strategy, governance and commercial law. Kate's board experience has spanned commercial, statutory and not-for-profit entities across diverse sectors: banking and finance; engineering; defence; biotech; entertainment; gaming; software; education; employment; housing and accommodation and professional services. She is a Director of Whittles Management Services Pty Ltd, a trustee of Adelaide Workers' Homes and a member of the Diocesan Finance Council of the Adelaide Archdiocese of the Catholic Church. She is an expert in corporate governance, board performance and strategy.
|
Lishan Zhang |
|
N/A |
|
Simon Buckingham |
|
N/A |
|
Christopher Catlow |
|
N/A |
|
William Rowley |
|
N/A |
|
Lee Rodne |
|
N/A |
|
Michael Bennett |
|
N/A |
|